Prediction of immunochemotherapy response for diffuse large B‐cell lymphoma using artificial intelligence digital pathology
Abstract Diffuse large B‐cell lymphoma (DLBCL) is a heterogeneous and prevalent subtype of aggressive non‐Hodgkin lymphoma that poses diagnostic and prognostic challenges, particularly in predicting drug responsiveness. In this study, we used digital pathology and deep learning to predict responses...
Saved in:
Main Authors: | Jeong Hoon Lee (Author), Ga‐Young Song (Author), Jonghyun Lee (Author), Sae‐Ryung Kang (Author), Kyoung Min Moon (Author), Yoo‐Duk Choi (Author), Jeanne Shen (Author), Myung‐Giun Noh (Author), Deok‐Hwan Yang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacodynamics of Rivaroxaban and Dabigatran in Adults with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy
by: Teerachat Punnachet, et al.
Published: (2024) -
More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features
by: Lucijanic M, et al.
Published: (2021) -
A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
by: Yang Y, et al.
Published: (2023) -
Targeting MDR1-P-glycoprotein (MDR1-Pgp) in immunochemotherapy of acute myeloid leukemia (AML)
by: Maurizio Cianfriglia
Published: (2013) -
Pan-Immune-Inflammatory Value in Patients with Non-Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy
by: Zhai WY, et al.
Published: (2023)